Document Detail


Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
MedLine Citation:
PMID:  15705907     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dihydropyrimidine dehydrogenase is the most extensively investigated predictive marker for individual response to 5-fluorouracil. Clinical responses to the anticancer agent, along with various reports, have clearly shown that dihydropyrimidine dehydrogenase activity is closely correlated to its mRNA levels, but the regulatory mechanisms of its expression have remained unclear. We attempted to clarify the mechanisms and found that activator protein (AP-1) is probably one of the key factors in the transcriptional regulation of DPYD in cancer cells, and that phorbol 12-myristate 13-acetate (PMA) plus ionomycin treatment enhances transcription of DPYD via AP-1 activation. In this study, we characterized our previously subcloned 5' region of human DPYD, an approximately 3.0-kb fragment (accession no. AB162145). Luciferase reporter assay showed that the clone showed strong promoter activities in 293T and HSC42 cells, and comparative analysis using 5' deletion mutants suggested the existence of several positive and negative regulatory regions, including putative binding sites for AP-1, SP-1, and nuclear factor-kappaB. PMA/ionomycin treatment increased the mRNA level of DPYD in HSC42 cells, and electrophoretic gel mobility shift assay showed that the complex on the putative AP-1 binding site was drastically induced by PMA/ionomycin treatment. The complexes formed were competed out by preincubation with the cold-consensus AP-1 binding site, and the DNA binding complex formed on the site contained c-Jun and c-Fos, which are components of AP-1 transcription factor. We further identified the functional AP-1 binding site (nucleotide positions from -290 to -280), whose nucleotide mutations abolished PMA/ionomycin-induced DPYD promoter activation.
Authors:
Kei Ukon; Keiji Tanimoto; Tatsushi Shimokuni; Takuya Noguchi; Keiko Hiyama; Hiroaki Tsujimoto; Masakazu Fukushima; Tetsuya Toge; Masahiko Nishiyama
Related Documents :
17549507 - Characterization of a new sumo-1 nuclear body (snb) enriched in pcreb, cbp, c-jun in ne...
10924947 - Exploration of a novel environment leads to the expression of inducible transcription f...
25378077 - Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocel...
8632147 - Induction of proenkephalin gene expression in cultured bovine chromaffin cells is depen...
22328717 - The unliganded glucocorticoid receptor positively regulates the tumour suppressor gene ...
17393107 - Role of connective tissue growth factor in extracellular matrix degradation in renal tu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer research     Volume:  65     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-11     Completed Date:  2005-03-14     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1055-62     Citation Subset:  IM    
Affiliation:
Departments of Translational Cancer Research and Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Binding Sites
Cell Line, Transformed
Cell Line, Tumor
Dihydrouracil Dehydrogenase (NADP) / biosynthesis,  genetics*
Humans
Ionomycin / pharmacology
Kidney / enzymology,  physiology
Promoter Regions, Genetic
RNA, Messenger / biosynthesis,  genetics
Stomach Neoplasms / enzymology*,  genetics
Tetradecanoylphorbol Acetate / pharmacology
Transcription Factor AP-1 / genetics,  metabolism,  physiology*
Transcription, Genetic / drug effects,  physiology*
Transcriptional Activation / drug effects,  physiology
Transfection
Tumor Markers, Biological / biosynthesis,  genetics
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/Transcription Factor AP-1; 0/Tumor Markers, Biological; 16561-29-8/Tetradecanoylphorbol Acetate; 56092-81-0/Ionomycin; EC 1.3.1.2/Dihydrouracil Dehydrogenase (NADP)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells ...
Next Document:  Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 p...